; and (C) state with particularity all damages or other remedies sought in the proceeding. (2) Excluding legal counsel for the designated entity involved, neither the designated entity nor the agents or representatives of the designated entity may obtain through discovery, or by other means, any non-public information of any entity or person related to any technical features or operation of a product or service. (3) Upon the filing of the affected proceeding, the designated entity involved shall provide notice of the proceeding to the Department of Justice and the United States Patent and Trademark Office. (4) The United States shall have the unconditional right to intervene as a party in the proceeding under rule 24(a) of the Federal Rules of Civil Procedure. (c) Restrictions on certain patent transactions Notwithstanding any other provision of law or regulation, the following requirements shall apply with respect to the sale or exclusive license of a patent issued by the United States Patent and Trademark Office: (1) The sale or license is prohibited if the sale or license is to a designated entity and the entity has not undergone review under section 721 of the Defense Production Act of 1950 ( 50 U.S.C. 4565 ). (2) The sale or license is prohibited if the sale or license is to or by a designated entity and the manufacture, sale, use, import, or export of a product or service that is subject to the covered regulations would infringe the patent, unless an appropriate license is granted under the covered regulations. (3) With respect to a patent not involving a drug or biological product, the sale or license of the patent to or by a designated entity to any foreign entity or affiliate shall require notification pursuant to rules under subsection (d)(1), and the waiting period described in subsection (b)(1), of section 7A of the Clayton Act ( 15 U.S.C. 18a ), notwithstanding any other provision of that Act. (d) List The Under Secretary of Commerce for Intellectual Property and Director of the United States Patent